Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance

Bor-Shyang Sheu, Cheng Tang Chiu, Yi Chia Lee, Chi Yang Chang, Deng Chyang Wu, Jyh Ming Liou, Ming Shiang Wu, Wei-Lun Chang, Chun Ying Wu, Jaw Town Lin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Summary Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical complication in the Orient. The consensus comprises recommendations to GERD control under the advantage of endoscopy-based approach covered by the Taiwan National Health Insurance. Methods The steering committee defined the consensus scope to cover diagnostic, therapeutic, unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The literature review emphasized domestic data, after which the draft statements and statement evidence levels were defined. Thirty-five experts of GERD in Taiwan formed the expert group to conduct the consensus conference by a modified Delphi process to vote anonymously to reach a consensus, defined by an agreement of ≥ 80% for each statement, and to set the recommendation grade. Results The consensus included 22 statements, including seven on diagnostic approach, seven on therapeutic suggestion, and eight on unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The consensus highlighted that the endoscopy approach to GERD can define the disease spectrum and exclude malignant potential. The questionnaire survey can not only define GERD, but also monitor treatment response and quality of life. The consensus addressed suggestions for the unresolved issues related to extraesophageal presentation and adverse concerns of GERD after long-term use of proton pump inhibitors. In the endemic area of upper gastrointestinal cancers, Helicobacter pylori eradication is suggested to reduce progression of gastric precancerous lesions, and endoscopic surveillance of Barrett's esophagus with dysplasia deserves prospective research. Conclusion The consensus comprises recommendations for the management of GERD in a high upper gastrointestinal cancer area with a national coverage of endoscopic approach.

Original languageEnglish
Article number79
Pages (from-to)85-94
Number of pages10
JournalAdvances in Digestive Medicine
Volume2
Issue number3
DOIs
Publication statusPublished - 2015 Sep 1

Fingerprint

National Health Programs
Gastroesophageal Reflux
Taiwan
Endoscopy
Proton Pump Inhibitors
Gastrointestinal Neoplasms
Barrett Esophagus
Helicobacter pylori
Stomach
Quality of Life
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Sheu, Bor-Shyang ; Chiu, Cheng Tang ; Lee, Yi Chia ; Chang, Chi Yang ; Wu, Deng Chyang ; Liou, Jyh Ming ; Wu, Ming Shiang ; Chang, Wei-Lun ; Wu, Chun Ying ; Lin, Jaw Town. / Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance. In: Advances in Digestive Medicine. 2015 ; Vol. 2, No. 3. pp. 85-94.
@article{641c97a974754e769e56fed6d2f7f495,
title = "Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance",
abstract = "Summary Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical complication in the Orient. The consensus comprises recommendations to GERD control under the advantage of endoscopy-based approach covered by the Taiwan National Health Insurance. Methods The steering committee defined the consensus scope to cover diagnostic, therapeutic, unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The literature review emphasized domestic data, after which the draft statements and statement evidence levels were defined. Thirty-five experts of GERD in Taiwan formed the expert group to conduct the consensus conference by a modified Delphi process to vote anonymously to reach a consensus, defined by an agreement of ≥ 80{\%} for each statement, and to set the recommendation grade. Results The consensus included 22 statements, including seven on diagnostic approach, seven on therapeutic suggestion, and eight on unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The consensus highlighted that the endoscopy approach to GERD can define the disease spectrum and exclude malignant potential. The questionnaire survey can not only define GERD, but also monitor treatment response and quality of life. The consensus addressed suggestions for the unresolved issues related to extraesophageal presentation and adverse concerns of GERD after long-term use of proton pump inhibitors. In the endemic area of upper gastrointestinal cancers, Helicobacter pylori eradication is suggested to reduce progression of gastric precancerous lesions, and endoscopic surveillance of Barrett's esophagus with dysplasia deserves prospective research. Conclusion The consensus comprises recommendations for the management of GERD in a high upper gastrointestinal cancer area with a national coverage of endoscopic approach.",
author = "Bor-Shyang Sheu and Chiu, {Cheng Tang} and Lee, {Yi Chia} and Chang, {Chi Yang} and Wu, {Deng Chyang} and Liou, {Jyh Ming} and Wu, {Ming Shiang} and Wei-Lun Chang and Wu, {Chun Ying} and Lin, {Jaw Town}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.aidm.2015.05.002",
language = "English",
volume = "2",
pages = "85--94",
journal = "Advances in Digestive Medicine",
issn = "2351-9797",
publisher = "Elsevier Taiwan LLC",
number = "3",

}

Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance. / Sheu, Bor-Shyang; Chiu, Cheng Tang; Lee, Yi Chia; Chang, Chi Yang; Wu, Deng Chyang; Liou, Jyh Ming; Wu, Ming Shiang; Chang, Wei-Lun; Wu, Chun Ying; Lin, Jaw Town.

In: Advances in Digestive Medicine, Vol. 2, No. 3, 79, 01.09.2015, p. 85-94.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance

AU - Sheu, Bor-Shyang

AU - Chiu, Cheng Tang

AU - Lee, Yi Chia

AU - Chang, Chi Yang

AU - Wu, Deng Chyang

AU - Liou, Jyh Ming

AU - Wu, Ming Shiang

AU - Chang, Wei-Lun

AU - Wu, Chun Ying

AU - Lin, Jaw Town

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Summary Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical complication in the Orient. The consensus comprises recommendations to GERD control under the advantage of endoscopy-based approach covered by the Taiwan National Health Insurance. Methods The steering committee defined the consensus scope to cover diagnostic, therapeutic, unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The literature review emphasized domestic data, after which the draft statements and statement evidence levels were defined. Thirty-five experts of GERD in Taiwan formed the expert group to conduct the consensus conference by a modified Delphi process to vote anonymously to reach a consensus, defined by an agreement of ≥ 80% for each statement, and to set the recommendation grade. Results The consensus included 22 statements, including seven on diagnostic approach, seven on therapeutic suggestion, and eight on unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The consensus highlighted that the endoscopy approach to GERD can define the disease spectrum and exclude malignant potential. The questionnaire survey can not only define GERD, but also monitor treatment response and quality of life. The consensus addressed suggestions for the unresolved issues related to extraesophageal presentation and adverse concerns of GERD after long-term use of proton pump inhibitors. In the endemic area of upper gastrointestinal cancers, Helicobacter pylori eradication is suggested to reduce progression of gastric precancerous lesions, and endoscopic surveillance of Barrett's esophagus with dysplasia deserves prospective research. Conclusion The consensus comprises recommendations for the management of GERD in a high upper gastrointestinal cancer area with a national coverage of endoscopic approach.

AB - Summary Background and aims Gastroesophageal reflux disease (GERD) is emerging as a clinical complication in the Orient. The consensus comprises recommendations to GERD control under the advantage of endoscopy-based approach covered by the Taiwan National Health Insurance. Methods The steering committee defined the consensus scope to cover diagnostic, therapeutic, unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The literature review emphasized domestic data, after which the draft statements and statement evidence levels were defined. Thirty-five experts of GERD in Taiwan formed the expert group to conduct the consensus conference by a modified Delphi process to vote anonymously to reach a consensus, defined by an agreement of ≥ 80% for each statement, and to set the recommendation grade. Results The consensus included 22 statements, including seven on diagnostic approach, seven on therapeutic suggestion, and eight on unresolved, controversial, or long-term proton pump inhibitor-related issues to GERD. The consensus highlighted that the endoscopy approach to GERD can define the disease spectrum and exclude malignant potential. The questionnaire survey can not only define GERD, but also monitor treatment response and quality of life. The consensus addressed suggestions for the unresolved issues related to extraesophageal presentation and adverse concerns of GERD after long-term use of proton pump inhibitors. In the endemic area of upper gastrointestinal cancers, Helicobacter pylori eradication is suggested to reduce progression of gastric precancerous lesions, and endoscopic surveillance of Barrett's esophagus with dysplasia deserves prospective research. Conclusion The consensus comprises recommendations for the management of GERD in a high upper gastrointestinal cancer area with a national coverage of endoscopic approach.

UR - http://www.scopus.com/inward/record.url?scp=84983116906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983116906&partnerID=8YFLogxK

U2 - 10.1016/j.aidm.2015.05.002

DO - 10.1016/j.aidm.2015.05.002

M3 - Article

AN - SCOPUS:84983116906

VL - 2

SP - 85

EP - 94

JO - Advances in Digestive Medicine

JF - Advances in Digestive Medicine

SN - 2351-9797

IS - 3

M1 - 79

ER -